Your browser doesn't support javascript.
The implementation of a FIP guidance for COVID-19: insights from a nationwide survey.
Yi, Zhan-Miao; Song, Zai-Wei; Li, Xin-Ya; Hu, Yang; Cheng, Yin-Chu; Wang, Guan-Ru; Zhao, Rong-Sheng.
  • Yi ZM; Department of Pharmacy, Peking University Third Hospital, Beijing, China.
  • Song ZW; Institute for Drug Evaluation, Peking University Health Science Center, Beijing, China.
  • Li XY; Therapeutic Drug Monitoring and Clinical Toxicology Center, Peking University, Beijing, China.
  • Hu Y; Department of Pharmacy, Peking University Third Hospital, Beijing, China.
  • Cheng YC; Institute for Drug Evaluation, Peking University Health Science Center, Beijing, China.
  • Wang GR; Therapeutic Drug Monitoring and Clinical Toxicology Center, Peking University, Beijing, China.
  • Zhao RS; Department of Pharmacy, Peking University Third Hospital, Beijing, China.
Ann Transl Med ; 9(18): 1479, 2021 Sep.
Article in English | MEDLINE | ID: covidwho-1458479
ABSTRACT

BACKGROUND:

The International Pharmaceutical Federation (FIP) has established an interim guidance of coronavirus disease 2019 (COVID-19) for pharmacists worldwide. The aim of this study was to identify the implementation of FIP guidance in China and provide applicable strategies for further actions.

METHODS:

A nationwide cross-sectional survey on Chinese pharmacists was distributed electronically through groups of WeChat between 9 December 2020 and 18 December 2020. The 29-item questionnaire for the survey was designed based on the FIP guidance and knowledge, attitudes, and practices (KAP) framework.

RESULTS:

A total of 237 responses from 237 pharmacists (69.20% females) were received. Most pharmacists (81.86%) participated in work related to COVID-19. Respondents referred to other guidelines or consensus more than they did to FIP guidance. Most participants were qualified for the knowledge-based questions regarding COVID-19 (67.51%), had positive attitudes towards pharmacists' roles and actions (61.18%), and were qualified in the practices of prevention measures, infection risk monitoring, and pharmacists' advice (50.63%). Several factors were revealed as having impact on pharmacists' KAP, such as the relevance of participating in work related to COVID-19, work entailments, and information source.

CONCLUSIONS:

The FIP guidance has a certain degree of dissemination and implementation in China, which can be improved through effective actions directed towards impact factors.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Language: English Journal: Ann Transl Med Year: 2021 Document Type: Article Affiliation country: Atm-21-4157

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Language: English Journal: Ann Transl Med Year: 2021 Document Type: Article Affiliation country: Atm-21-4157